Viatris Receives FDA Approval for RYZUMVI Presbyopia Treatment
The FDA approved Viatris’ RYZUMVI (phentolamine ophthalmic solution 0.75%) for treating presbyopia in adults.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.